The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
about
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine developmentComplicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilisMucosal immunization with iron receptor antigens protects against urinary tract infection.Towards a vaccine against Escherichia coli-associated urinary tract infections.Waging war against uropathogenic Escherichia coli: winning back the urinary tractThe battle for iron between bacterial pathogens and their vertebrate hosts.Escherichia coli global gene expression in urine from women with urinary tract infection.α-Intercalated cells defend the urinary system from bacterial infectionIdentification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coliA multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coliA killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.Establishment and Characterization of UTI and CAUTI in a Mouse Model.Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli.Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss.Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development.Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.Rising Cellular Immune Response after Injection of pVax/iutA: A Genetic DNA Cassette as Candidate Vaccine against Urinary Tract Infection.From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infectionsAn "omics" approach to uropathogenic Escherichia coli vaccinology.The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro.Determination of heme in microorganisms using HPLC-MS/MS and cobalt(III) protoporphyrin IX inhibition of heme acquisition in Escherichia coli.Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains.
P2860
Q21328677-FC1D9B73-C8B4-481A-AD79-25338F42132EQ30491878-2D209EBB-158E-4F9D-AF20-24AD5EC59EE7Q33508792-F68B098F-F0DE-4D21-B14A-781143BF9A50Q33538262-E88DC008-8F35-429C-9CC4-C53E7304548BQ33613902-0C2D6A24-CFD6-4DA1-B522-3D2FBCB0DD3EQ33658687-EC9ED081-E7A6-4140-B59C-A2A6574BCA19Q33750030-CFE1BE05-3936-45B5-ACBD-4FAC6C4B6B65Q33808284-F202F20E-D253-4DFB-BC06-041C95AA88CBQ33927393-617CF3B0-D12B-4B71-94DC-AB993FF5A394Q34045099-61957C63-2AA5-4071-ABB5-628F742ADCB6Q34641267-4A46C9AD-B3B1-4B79-9104-AFA433486B6EQ35783832-0B26A0B2-42DD-4D17-A431-A70531AA0574Q35878788-A5C446A1-37C0-4E1B-BDB5-2F7BD086791CQ35949664-C0025451-658F-4930-BA6D-BC0117AB3176Q35980554-0C228CA0-B446-45A7-8440-AD2D6BC6663BQ36124083-148018EE-1623-42C5-AE0B-5A7C4BC303B1Q36275489-98F3C22F-BE9F-4667-B8D5-2F6FDB1328A9Q36383799-7452633B-0FA4-48C4-87CC-111A7ED25B44Q36471330-94B7EC12-1D83-416F-965E-6B4E11632D3CQ36845213-64EB216D-F359-4A6E-9452-69CF86F4CEADQ36951570-1BDE4FCE-92A7-4F0F-8C55-32B60821D25EQ37123720-22C7110D-4A8F-43BD-BE2C-CF8C7BB7BFD8Q37165905-FC4F6F79-E507-45F2-9A76-D5162D714B7AQ37230837-081B08CB-2114-44B0-9AA9-924E8FDF7B3BQ37404993-9CCD3585-C999-4D77-B089-A2B8A8FFA40CQ42432483-1CB4778E-A977-4D19-80FF-8F667C1C7C01Q49229396-56E85F33-5292-484A-859A-E766CD03ADF0Q54326043-DE2C45A4-4381-45B0-88A2-A79F0298654E
P2860
The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The Siderophore receptor IroN ...... a potential vaccine candidate.
@ast
The Siderophore receptor IroN ...... a potential vaccine candidate.
@en
The Siderophore receptor IroN ...... a potential vaccine candidate.
@nl
type
label
The Siderophore receptor IroN ...... a potential vaccine candidate.
@ast
The Siderophore receptor IroN ...... a potential vaccine candidate.
@en
The Siderophore receptor IroN ...... a potential vaccine candidate.
@nl
prefLabel
The Siderophore receptor IroN ...... a potential vaccine candidate.
@ast
The Siderophore receptor IroN ...... a potential vaccine candidate.
@en
The Siderophore receptor IroN ...... a potential vaccine candidate.
@nl
P2093
P2860
P1476
The Siderophore receptor IroN ...... a potential vaccine candidate.
@en
P2093
Catherine D McFadden
Gregory E Wilding
Janet M Beanan
Ruth Olson
Thomas A Russo
Ulrike B Carlino-MacDonald
P2860
P304
P356
10.1128/IAI.71.12.7164-7169.2003
P407
P577
2003-12-01T00:00:00Z